Price T Rowe Associates Inc Kura Oncology, Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 23,726 shares of KURA stock, worth $210,212. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,726
Previous 23,054
2.91%
Holding current value
$210,212
Previous $475,000
2.32%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding KURA
# of Institutions
185Shares Held
81.8MCall Options Held
42.1KPut Options Held
34K-
Suvretta Capital Management, LLC New York, NY7.65MShares$67.8 Million5.88% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$61.7 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$51.4 Million4.92% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$47.9 Million1.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.33MShares$38.4 Million3.05% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $593M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...